0241.HK

Online medical services provider Alibaba Health Information Technology Ltd. (0241.HK) said Wednesday its revenue rose 10.2% year-on-year to 14.27 billion yuan ($1.98 billion) in the six months through September. It credited the growth to a 67.5% jump in revenue from its pharmaceutical e-commerce platform business, which was partly offset by a 9.4% drop in revenue from its healthcare and digital services business.

The company’s net profit during the period, the first half of its fiscal year, surged by 72.5% to 770 million yuan. It attributed the strong gains to the revenue increase, as well as improving operational efficiencies for its self-operated pharmaceutical business, including its introduction of more top brands and expansion of its partnership channels.

The company’s stock rose 3.3% to HK$4.27 in early Thursday trade in Hong Kong.

By A. Au

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Noah does wealth management

Noah finds second life in overseas voyage

The wealth manager’s international businesses drove it back to revenue growth in the second quarter as challenges continued to linger at home Key Takeaways: Noah Holdings’ overseas revenue increased about…
Illustration of China solar industry

China moves to end solar bloodbath, as East Buy chases warehouse club crown

China is floating yet another plan to rescue its oversupplied solar sector, including a mass shuttering of excess capacity. Will the government-led effort work this time? And a former online educator says it wants to become the new online Sam's Club of China. Does East Buy have what it takes to succeed?